Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing

Bibliographic Details
Title: Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
Authors: Laurentijn Tilleman, Kaat Rubben, Wim Van Criekinge, Dieter Deforce, Filip Van Nieuwerburgh
Source: Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Publisher Information: Nature Portfolio, 2022.
Publication Year: 2022
Collection: LCC:Medicine
LCC:Science
Subject Terms: Medicine, Science
More Details: Abstract The currently used pharmacogenetic genotyping assays offer limited haplotype information, which can potentially cause specific functional effects to be missed. This study tested if Targeted Locus Amplification (TLA), when using non-patient-specific primers combined with Illumina or Nanopore sequencing, can offer an advantage in terms of accurate phasing. The TLA method selectively amplifies and sequences entire genes based on crosslinking DNA in close physical proximity. This way, DNA fragments that were initially further apart in the genome are ligated into one molecule, making it possible to sequence distant variants within one short read. In this study, four pharmacogenes, CYP2D6, CYP2C19, CYP1A2 and BRCA1, were sequenced after enrichment using different primer pairs. Only 24% or 38% of the nucleotides mapped on target when using Illumina or Nanopore sequencing, respectively. With an average depth of more than 1000X for the regions of interest, none of the genes were entirely covered with either sequencing method. For three of the four genes, less than half of the variants were phased correctly compared to the reference. The Nanopore dataset with the optimized primer pair for CYP2D6 resulted in the correct haplotype, showing that this method can be used for reliable genotyping and phasing of pharmacogenes but does require patient-specific primer design and optimization to be effective.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-2322
Relation: https://doaj.org/toc/2045-2322
DOI: 10.1038/s41598-022-22499-0
Access URL: https://doaj.org/article/8dac01e2cff74827bcd4cde1082786a7
Accession Number: edsdoj.8dac01e2cff74827bcd4cde1082786a7
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20452322
DOI:10.1038/s41598-022-22499-0
Published in:Scientific Reports
Language:English